Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cattle TB vaccine field trials begin next phase
Phase 3 of the cattle TB vaccine trials are getting underway in England and Wales.  
 

New vaccine has the potential to protect animals and prevent transmission. 

The Animal Plant Health Agency (APHA) has confirmed a third phase of field trials for a cattle vaccine and companion skin test for bovine tuberculosis (bTB). 

The trials, which are taking place on commercial livestock farms across the Low-Risk Area in England and the Low TB Area in Wales, are scheduled for completion in 2026. 

Phase one and two successfully demonstrated that BCG and its companion Detect Infected among Vaccinated animals (DIVA) skin test are safe to use. The third phase of the trials will gather further data on the performance of the DIVA test and explore options for optimisation. 

UK chief veterinary officer, Christine Middlemiss, added: “The UK is at the forefront of global efforts to develop effective TB cattle vaccines, and we are moving ever closer to having an operable vaccine.
 
“That we are reaching this stage is testament to our world leading scientists in organisations like the Animal Plant Health Agency, but also to the vets and farmers that have taken part in this trial and previous trials.
 
“If this next phase is successful, we are one step closer to a vaccine which used in conjunction with other measures will help tackle this insidious disease that impacts livestock farmers across the globe.”

Phase 3 will involve at least 10 farms with a total of 750 animals participating. All the animals enrolled will receive the CattleBCG vaccine and the companion DIVA skin test.

Upon completion, APHA will use data from all three trials to support applications for GB Marketing Authorisations for both the cattle vaccine and the skin test. 

Dr Camille Szmaragd Harrison, lead scientist for TB at the APHA, said: “Launching this next phase of the trials has been a collective effort, which was only made possible by the unfailing support from across the farming industry. The team and I are particularly grateful to the hundreds of farmers who expressed their interest in taking part in this trial, without them this would not have been possible.” 

Chief veterinary officer for Wales, Richard Irvine, added: “I welcome the start of Phase 3 of the field trials on a farm in Wales. It marks another important step towards having a deployable Cattle TB Vaccine to support the eradication of TB from the national herd and to meet the target of a TB free Wales by 2041.”


Image © de Videomakers/Shutterstock.com

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
RCVS Regional Question Time heads to Edinburgh

The RCVS is to bring its Regional Question Time (RQT) to Edinburgh for 2026.

The event will take place at Novotel Edinburgh Park in Edinburgh on Wednesday, 20 May 2026.

It will begin with supper and drinks at 6.30pm, with an evening programme from 7.30pm. This will start with an update on RCVS' activities, followed by questions and answers with representatives.

RCVS is encouraging an 'open dialogue', in which queries can be raised in a friendly, informal environment.

While discussions are expected to be audience-led, the RQT is expected address major issues including the VSA, the CMA's remedy package and the VN Vision project.

Tim Parkin, RCVS president, said: "It's an important time for the professions, and I'm looking forward to meeting colleagues in Scotland as we navigate this period of change together so we can come out stronger."

Tickets can be booked here.